NDC 13668-0014 - Levetiracetam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 13668-0014
- Manufacturer
- Rebel Distributors Corp
- Effective date
- 2010-09-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levetiracetam - Rebel Distributors Corp | Rebel Distributors Corp | 2010-09-30 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| LEVETIRACETAM | ACTIVE INGREDIENT | 44YRR34555 | LEVETIRACETAM TABLET [REBEL DISTRIBUTORS CORP] | 1 | |
| LEVETIRACETAM | ACTIVE MOIETY | 44YRR34555 | LEVETIRACETAM TABLET [REBEL DISTRIBUTORS CORP] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LEVETIRACETAM | LEVETIRACETAM | Solco Healthcare US, LLC | cfe618ae-f7de-43d8-a754-3ce0a08c48ee | 2025-03-26 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Preferred Pharmaceuticals Inc. | 8c16bc7b-672c-420a-a457-350060533375 | 2025-03-20 | Warnings, Adverse reactions | 311289 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | A-S Medication Solutions | c82313cb-744f-45ef-b74c-1bdd055b2193 | 2025-03-18 | Warnings, Adverse reactions | 311289 44YRR34555 |
| LEVETIRACETAM | LEVETIRACETAM | Kesin Pharma Corporation | 30a4626d-74f3-6385-e063-6394a90a2950 | 2025-03-01 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | PD-Rx Pharmaceuticals, Inc. | c2177034-e164-453c-be02-1cf91ce27a07 | 2025-02-28 | Warnings, Adverse reactions | ANDA078858 311289 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | American Health Packaging | 3be7c30b-f35d-4dde-8bf8-24f67bd70865 | 2025-02-18 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Coupler LLC | 2d596153-c49b-273f-e063-6294a90ac663 | 2025-02-04 | Warnings, Adverse reactions | 387003 44YRR34555 |
| Levetiracetam ER | LEVETIRACETAM ER | Direct_Rx | 03c449a1-9b40-a7da-e063-6394a90a984e | 2025-01-22 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Torrent Pharmaceuticals Limited | 6ab24168-058d-496e-9023-da8ee6353eb3 | 2025-01-22 | Warnings, Adverse reactions | ANDA078858 13668-016 13668-017 13668-015 311288 387003 311290 311289 b8792837-f86a-4e67-b1a5-ec8ca278fe77 6ab24168-058d-496e-9023-da8ee6353eb3 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | NCS HealthCare of KY, LLC dba Vangard Labs | dfb7c640-623e-43d1-8ee8-479dccd53d0a | 2025-01-16 | Warnings, Adverse reactions | 311288 387003 311290 311289 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Novadoz Pharmaceuticals LLC | 1c4450a1-6c05-4b45-a733-c19b4e861970 | 2024-12-31 | Warnings, Adverse reactions | 311288 387003 311290 311289 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | BluePoint Laboratories | 8b74b8bc-d95c-4471-8f74-c3117243bf89 | 2024-12-11 | Warnings, Adverse reactions | 311288 387003 311290 311289 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | American Health Packaging | fc8bf57e-8aa2-4d3c-856d-b19de65e3ba0 | 2024-11-18 | Warnings, Adverse reactions | 311288 311290 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | A-S Medication Solutions | 8a8472dc-b97e-445d-bf51-b6e618cae1b6 | 2024-10-21 | Warnings, Adverse reactions | 387003 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | NorthStar Rx LLC | 483a42b9-c8f3-4f8b-98be-fcac5ab23c7c | 2024-10-14 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | XLCare Pharmaceuticals Inc. | 567f09e6-ccd5-4688-a22b-0bc66a5fe31e | 2024-09-06 | Warnings, Adverse reactions | 311288 387003 311290 311289 44YRR34555 |
| levetiracetam | LEVETIRACETAM | Novadoz Pharmaceuticals LLC | 1ec4c05d-7fba-4c02-a3bf-4343a8a421d5 | 2024-08-28 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Bryant Ranch Prepack | b738377c-035e-4b2e-9909-0a8fe07aa0fb | 2024-08-12 | Warnings, Adverse reactions | ANDA078858 311289 44YRR34555 |
| Levetiracetam | LEVETIRACETAM ORAL | Camber Pharmaceuticals, Inc. | 0bc8468f-832c-4e71-95a2-db464d4d54bc | 2024-08-03 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | ScieGen Pharmaceuticals, Inc. | 1d71212b-ac97-4a61-8192-8e8303540019 | 2024-08-01 | Warnings, Adverse reactions | 311288 387003 311290 311289 44YRR34555 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.